The West Michigan Science & Technology Initiative will hold its annual SUMmIT10 event, exploring the impact of Health Care Reform on innovation and entrepreneurship in the areas of drugs, diagnostics and devices.
The event will be held Tuesday, September 28, beginning at 8:30 a.m., in Loosemore Auditorium at the DeVos Center, Pew Grand Rapids Campus.
While the law is still being debated, interpreted, and reduced to regulations, the impacts on innovation, product development and conducting business are becoming clear for these three areas of interest. Speakers will discuss how this new law will likely affect these areas in the future.
7:30-8:30 a.m., Registration and continental breakfast
8:30-10:30 a.m., Keynote and company presentations
11 a.m.-noon, Panel discussion
Roger S. Newton, founder, CEO and president, and director of Esperion Therapeutics, Inc.
James J. Herrmann, co-founder and chief operating officer, Tolera Therapeutics
Kevin McCurren, president, Intervention Insights, LLC
Justin Adams, CEO and president, mHealth Innovations, Inc.
Kathrin E. Kudner, Dykema
The cost of the event is $35. For more information, contact the West Michigan Science & Technology Initiative at (616) 331-5840 or email email@example.com.